Akshay Desai, MD
Enriched profileMedical Director, Cardiomyopathy and Heart Failure Program, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School · Brigham and Women's Hospital
Akshay Desai is Medical Director, Cardiomyopathy and Heart Failure Program, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital. OpenAlex indexes 652 publications with 57,900 citations (h-index 102); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Akshay Desai, MD, is Medical Director, Cardiomyopathy and Heart Failure Program, Brigham and Women's Hospital. The public record shows 652 publications with 57,900 citations (h-index 102), centered on Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Diabetes Treatment and Management. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 28 companies, 2 NIH-funded awards (2021–2026).
- Most recent indexed publication: 2026 · Circulation. Heart failure
- Top research focus: Heart Failure Treatment and Management
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 28 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 47 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 350.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
Sponsor: Northwestern University
- HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
Sponsor: Northwestern University
Industry payments
Updated 27 Aug 2026
28 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20253 payments$14,525openpaymentsdata.cms.gov ↗
- Alnylam Pharmaceuticals Inc.Program year20258 payments
- Anumana, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.1%Beta blocker17%Metoprolol Succinate71%Carvedilol21%Atenolol4%Sotalol4%Part D<11 patientsStatin14.7%Atorvastatin Calcium68%Rosuvastatin Calcium27%Pravastatin Sodium6%Part D<11 patientsMetabolism & gastrointestinal
11.7%SGLT2 inhibitor9.8%Jardiance53%Farxiga42%Dapagliflozin5%Part D<11 patientsPotassium supplement0.7%Potassium Chloride100%Part D<11 patientsBlood & clotting
8.9%Factor Xa inhibitor7.4%Eliquis79%Xarelto21%Part D≥42 patientsP2Y12 inhibitor1.4%Clopidogrel100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- An AI-Assisted Strategy for Monitoring Pulmonary Congestion in Acute Heart Failure Patients in Emergency Settings
Brigham and Women'S Hospital
FY2026$673,366R01EB035679 - Mass General Brigham HeartShare Clinical Center
Massachusetts General Hospital
FY2026$425,681U01HL160278 - An AI-Assisted Strategy for Monitoring Pulmonary Congestion in Acute Heart Failure Patients in Emergency Settings
Brigham and Women'S Hospital
FY2025$693,116R01EB035679
Congress activity
Updated 27 Aug 2026
1 congress contribution (2020) across ADA per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Changes in Upright Hemodynamics Preceding Heart Failure Events and Other Hospitalizations.
European journal of heart failure
Article2026 - Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial.
European journal of heart failure
Clinical Trial2026 - Heart rate and atrial fibrillation/flutter in HFmrEF/HFpEF: a participant-level analysis across five randomized clinical trials.
European journal of heart failure
Article2026 - Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF Trial.
European journal of heart failure
Article2026
Most-cited works
by citation count (OpenAlex)- 01Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionArticle6,984 citations2019
- 02Angiotensin–Neprilysin Inhibition versus Enalapril in Heart FailureArticle6,894 citations2014
- 03Spironolactone for Heart Failure with Preserved Ejection FractionArticle2,745 citations2014
- 04Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection FractionArticle2,729 citations2022
- 05Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionArticle2,377 citations2019
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/akshay-desai-007251a
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Akshay-S-Desai-2210431860
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
hfsa.org/akshay-s-desai-md-mph-fhfsa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/the-lead-podcast-episode-53/id1696126287
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - Other
jacc.org/journal/heart-failure/podcasts
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jacc.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- Board certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗ - Board certified
Cardiovascular Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗ - Board certified
Advanced Heart Failure and Transplant Cardiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
- Deputy Editor
JACC: Heart Failure
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jacc.org ↗ - Fellow
Heart Failure Society of America (FHFSA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
Media & interviews
press, podcasts and appearances- JAMA Clinical Reviews podcast: 'Management of Heart Failure in 2019-2020
Part 1' - interviewed by JAMA Deputy Editor Ed Livingston, MD, at ESC Congress 2019
2019verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - ACC 'AI-Enabled Clinician' podcast: Heart Failure Prediction Using AI-Enabled ECG
with ACC Chief Innovation Officer Dr. Ami Bhatt
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital